DB, M., H, K., SA, C., E, M., K, N., R, M., . . . PA, S. (2025). Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer. Immunity, 58(7), 1688. https://doi.org/10.1016/j.immuni.2025.06.005
Chicago Style (17th ed.) CitationDB, Mahat, et al. "Mutant P53 Exploits Enhancers to Elevate Immunosuppressive Chemokine Expression and Impair Immune Checkpoint Inhibitors in Pancreatic Cancer." Immunity 58, no. 7 (2025): 1688. https://doi.org/10.1016/j.immuni.2025.06.005.
MLA (9th ed.) CitationDB, Mahat, et al. "Mutant P53 Exploits Enhancers to Elevate Immunosuppressive Chemokine Expression and Impair Immune Checkpoint Inhibitors in Pancreatic Cancer." Immunity, vol. 58, no. 7, 2025, p. 1688, https://doi.org/10.1016/j.immuni.2025.06.005.